BlackRock Investment Management, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 70 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2016$2,164,000
-5.8%
77,162
-0.3%
0.00%0.0%
Q3 2016$2,298,000
+47.3%
77,368
+0.4%
0.00%
+50.0%
Q2 2016$1,560,000
+160.4%
77,036
+132.0%
0.00%
+100.0%
Q1 2016$599,000
-30.5%
33,202
+1.5%
0.00%0.0%
Q4 2015$862,000
+24.2%
32,708
+0.6%
0.00%0.0%
Q3 2015$694,000
-21.2%
32,525
-2.2%
0.00%0.0%
Q2 2015$881,00033,2480.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2015
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders